Large-scale testing (Phase 3)Study completedNCT01121848What this trial is testingRandomized Study With Oxaliplatin in 2nd Line Pancreatic CancerWho this might be right forPancreatic Neoplasms Sanofi 108
Testing effectiveness (Phase 2)Study completedNCT00397787What this trial is testingSunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With GemcitabineWho this might be right forAcinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more National Cancer Institute (NCI) 64
Testing effectiveness (Phase 2)Study completedNCT01529827What this trial is testingFludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more Roswell Park Cancer Institute 94
Large-scale testing (Phase 3)Study completedNCT00099294What this trial is testingStudy of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer Threshold Pharmaceuticals 300
Testing effectiveness (Phase 2)Ended earlyNCT01834235What this trial is testingQUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic CancerWho this might be right forPancreatic Cancer, Adult Precision Biologics, Inc 81
Testing effectiveness (Phase 2)Study completedNCT03190265What this trial is testingStudy of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic CancerWho this might be right forPancreatic Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 61
Testing effectiveness (Phase 2)Ended earlyNCT02202785What this trial is testingMLN0264 in Patients With Pancreatic CancerWho this might be right forPancreatic Adenocarcinoma Millennium Pharmaceuticals, Inc. 43
Testing effectiveness (Phase 2)Study completedNCT02810418What this trial is testingMesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid TumorsWho this might be right forNeoplasmsPancreatic Neoplasms National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00126633What this trial is testingGemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer University of California, San Francisco 53
Testing effectiveness (Phase 2)Study completedNCT00652054What this trial is testingPhase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic CancerWho this might be right forMetastatic Pancreatic Cancer Taiho Oncology, Inc. 39
Early research (Phase 1)Looking for participantsNCT06983743What this trial is testingERAS-0015 in Patients With Advanced or Metastatic Solid TumorsWho this might be right forMetastatic Solid Tumors Erasca, Inc. 600
Testing effectiveness (Phase 2)Study completedNCT05014776What this trial is testingStudy of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 17
Testing effectiveness (Phase 2)Study completedNCT02551991What this trial is testingStudy of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic AdenocarcinomaWho this might be right forPancreatic Cancer Ipsen 56
Testing effectiveness (Phase 2)Study completedNCT00923299What this trial is testingCetuximab and Trastuzumab in Treating Patients With Metastatic Pancreatic Cancer That Progressed After Previous Treatment With GemcitabineWho this might be right forPancreatic Cancer Institut du Cancer de Montpellier - Val d'Aurelle 33
Large-scale testing (Phase 3)Ended earlyNCT00602745What this trial is testingS-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based RegimenWho this might be right forPancreatic NeoplasmNeoplasm Metastasis Sanofi 61
Testing effectiveness (Phase 2)Study completedNCT03410030What this trial is testingTrial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)Who this might be right forPancreatic CancerPancreas CancerPancreatic Adenocarcinoma Resectable+2 more HonorHealth Research Institute 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07561463What this trial is testingSacituzumab Tirumotecan for Pancreatic CancerWho this might be right forPancreatic Ductal Adenocarcinoma (PDAC) Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07784374What this trial is testingA Phase II Study of GFH375 Combined With GFS202A or GFH276 Versus GFH375 Monotherapy in Patients With Previously Treated Locally Advanced Unresectable or Metastatic Pancreatic Cancer Harboring KRAS G12D MutationWho this might be right forPancreatic Cancer Genfleet Therapeutics (Shanghai) Inc. 120
Large-scale testing (Phase 3)Looking for participantsNCT07262567What this trial is testingPhase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic CancerWho this might be right forMetastatic Pancreatic Cancer Genfleet Therapeutics (Shanghai) Inc. 320
Testing effectiveness (Phase 2)Study completedNCT01658943What this trial is testingSelumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With ChemotherapyWho this might be right forPancreatic Acinar Cell CarcinomaPancreatic Ductal AdenocarcinomaRecurrent Pancreatic Carcinoma+1 more National Cancer Institute (NCI) 137